Innovative Stroke Therapies
“Revolutionizing Stroke Treatment”
Developing a novel thrombolytic therapy to extend treatment windows and improve patient outcomes
Welcome to Rayyan Therapeutics, where innovation meets compassion. We are dedicated to developing safer and more effective stroke therapies, aiming to improve patient outcomes and quality of life.
Current Therapies Fall Short
Thrombolytics (tPA/TNK)
These clot-busting drugs are only effective within a narrow 4.5-hour window and carry a high risk of bleeding. Many patients arrive too late to benefit, and even those who qualify face serious safety concerns.
Blood Thinners
Antiplatelets and anticoagulants help prevent strokes, but they're not effective at dissolving existing clots. They're used long-term and often come with bleeding risks, dietary restrictions, and medication management challenges.
Mechanical Thrombectomy
A highly invasive procedure that uses a catheter threaded through the blood vessels to the brain. While effective in certain cases, it requires specialized medical teams and advanced hospital infrastructure, limiting its accessibility for many patients.
Novel Stroke Treatment Platform
The Rayyan therapy is a proprietary, non-immunogenic form of stabilized ADAMTS13 that enhances clot dissolution without increasing bleeding risk. By overcoming key limitations of current thrombolytics, it offers a safer and more precise solution for treating ischemic stroke.